Can early treatment of patients with risk factors contribute to managing the COVID-19 pandemic?

doi:10.7189/jogh.10.010377

Review

. 2020 Jun;10(1):010377.

doi: 10.7189/jogh.10.010377.

Can early treatment of patients with risk factors contribute to managing the COVID-19 pandemic?

Daniele Giammaria¹, Alessandro Pajewski²

Affiliations

¹ Ophthalmology Department, Azienda "Ospedali Riuniti Marche Nord", Pesaro, Italy.
² Gran Sasso Science Institute (GSSI), L'Aquila, Italy.

PMID: 32582439
PMCID: PMC7307801
DOI: 10.7189/jogh.10.010377

Review

Can early treatment of patients with risk factors contribute to managing the COVID-19 pandemic?

Daniele Giammaria et al. J Glob Health. 2020 Jun.

. 2020 Jun;10(1):010377.

doi: 10.7189/jogh.10.010377.

Authors

Daniele Giammaria¹, Alessandro Pajewski²

Affiliations

¹ Ophthalmology Department, Azienda "Ospedali Riuniti Marche Nord", Pesaro, Italy.
² Gran Sasso Science Institute (GSSI), L'Aquila, Italy.

PMID: 32582439
PMCID: PMC7307801
DOI: 10.7189/jogh.10.010377

No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors completed the ICMJE Unified Competing Interest form (available upon request from the corresponding author), and declare no conflicts of interest.

Figures

None — Photo: Image by Gerd Altmann from Pixabay.

See this image and copyright information in PMC

Cited by

Role of leukocytes and systemic inflammation indexes (NLR, PLR, MLP, dNLR, NLPR, AISI, SIR-I, and SII) on admission predicts in-hospital mortality in non-elderly and elderly COVID-19 patients.
Ghobadi H, Mohammadshahi J, Javaheri N, Fouladi N, Mirzazadeh Y, Aslani MR. Ghobadi H, et al. Front Med (Lausanne). 2022 Aug 18;9:916453. doi: 10.3389/fmed.2022.916453. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36059829 Free PMC article.
Evaluation of the Risk of Clinical Deterioration among Inpatients with COVID-19.
Costa VO, Nicolini EM, da Costa BMA, Teixeira FM, Ferreira JP, Moura MA, Montessi J, Campos RL, Guaraldo AN, Costa PM. Costa VO, et al. Adv Virol. 2021 Jun 25;2021:6689669. doi: 10.1155/2021/6689669. eCollection 2021. Adv Virol. 2021. PMID: 34257657 Free PMC article.
‎Factors associated with coronavirus disease 2019 infection severity among a sample of Lebanese adults: Data from a cross-sectional study.
El-Hayek E, Kahwagi GJ, Issy N, Tawil C, Younis N, Abou-Khalil R, Matar M, Hallit S. El-Hayek E, et al. Health Sci Rep. 2022 May 23;5(3):e654. doi: 10.1002/hsr2.654. eCollection 2022 May. Health Sci Rep. 2022. PMID: 35620538 Free PMC article.
Severe Acute Respiratory Syndrome Coronavirus 2 Diagnostic Tests for Border Screening During the Very Early Phase of Coronavirus Disease 2019 Pandemic: A Systematic Review and Meta-Analysis.
Chua PEY, Gwee SXW, Wang MX, Gui H, Pang J. Chua PEY, et al. Front Med (Lausanne). 2022 Feb 14;9:748522. doi: 10.3389/fmed.2022.748522. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35237618 Free PMC article.
Estimated Impact of Public and Private Sector COVID-19 Diagnostics and Treatments on US Healthcare Resource Utilization.
Sheinson DM, Wong WB, Solon CE, Cheng MM, Shah A, Elsea D, Meng Y. Sheinson DM, et al. Adv Ther. 2021 Feb;38(2):1212-1226. doi: 10.1007/s12325-020-01597-3. Epub 2020 Dec 26. Adv Ther. 2021. PMID: 33367984 Free PMC article.

See all "Cited by" articles

References

1. Giangreco G.Case fatality rate analysis of Italian COVID-19 outbreak. J Med Virol. 2020. Apr 16. 10.1002/jmv.25894 - DOI - PMC - PubMed
1. Mizumoto K, Kagaya K, Zarebski A, Chowell G.Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill. 2020;25:2000180. 10.2807/1560-7917.ES.2020.25.10.2000180 - DOI - PMC - PubMed
1. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Feb 24. https://jamanetwork.com/journals/jama/fullarticle/2762130. - PubMed
1. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR.Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19). The epidemic and the challenges. Int J Antimicrob Agents. 2020;55:105924. 10.1016/j.ijantimicag.2020.105924 - DOI - PMC - PubMed
1. Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2004;130:2620-9. 10.1172/JCI137244 - DOI - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources

[1] Giangreco G.Case fatality rate analysis of Italian COVID-19 outbreak. J Med Virol. 2020. Apr 16. 10.1002/jmv.25894 - DOI - PMC - PubMed

[2] Giangreco G.Case fatality rate analysis of Italian COVID-19 outbreak. J Med Virol. 2020. Apr 16. 10.1002/jmv.25894 - DOI - PMC - PubMed

[3] Mizumoto K, Kagaya K, Zarebski A, Chowell G.Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill. 2020;25:2000180. 10.2807/1560-7917.ES.2020.25.10.2000180 - DOI - PMC - PubMed

[4] Mizumoto K, Kagaya K, Zarebski A, Chowell G.Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill. 2020;25:2000180. 10.2807/1560-7917.ES.2020.25.10.2000180 - DOI - PMC - PubMed

[5] Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Feb 24. https://jamanetwork.com/journals/jama/fullarticle/2762130. - PubMed

[6] Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Feb 24. https://jamanetwork.com/journals/jama/fullarticle/2762130. - PubMed

[7] Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR.Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19). The epidemic and the challenges. Int J Antimicrob Agents. 2020;55:105924. 10.1016/j.ijantimicag.2020.105924 - DOI - PMC - PubMed

[8] Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR.Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19). The epidemic and the challenges. Int J Antimicrob Agents. 2020;55:105924. 10.1016/j.ijantimicag.2020.105924 - DOI - PMC - PubMed

[9] Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2004;130:2620-9. 10.1172/JCI137244 - DOI - PMC - PubMed

[10] Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2004;130:2620-9. 10.1172/JCI137244 - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Can early treatment of patients with risk factors contribute to managing the COVID-19 pandemic?

Affiliations

Can early treatment of patients with risk factors contribute to managing the COVID-19 pandemic?

Authors

Affiliations

Conflict of interest statement

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources